Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tamalpais Asset Management is a private investment firm and hedge fund based in Larkspur, California, that specializes in the life sciences and healthcare sectors. The firm focuses on identifying and investing in high-growth biotechnology, pharmaceutical, and medical technology companies through fundamental research and deep industry expertise. While not a drug developer itself, Tamalpais Asset Management plays a significant role in the biotech ecosystem by providing capital to emerging and established healthcare entities. The firm is known for its concentrated portfolio approach and its focus on therapeutic innovation and clinical-stage assets. Its investment strategy often targets companies with disruptive technologies or novel mechanisms of action in areas such as oncology, immunology, and rare diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tamalpais Asset Management.